Antiplatelet Therapy After Stent Placement

Introduction

The American College of Cardiology, American Heart Association, and European Society of Cardiology provide guidelines for antiplatelet therapy after stent placement to reduce the risk of stent thrombosis and cardiovascular events 1, 2, 3

The American College of Cardiology recommends a minimum of 1 month and up to 12 months of clopidogrel therapy after bare-metal stent placement, and at least 12 months for drug-eluting stents if the patient is not at high risk of bleeding 3
The American Heart Association and European Society of Cardiology recommend dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor for a minimum of 1 month, but ideally up to 12 months, for bare-metal stents and drug-eluting stents 2, 4, 3, 5
The European Society of Cardiology recommends 12 months of DAPT for all stented patients who are not at high risk of bleeding 1
P2Y12 inhibitors should be used for at least 12 months in ACS patients with stent, and for at least 12 months in non-ACS patients with DES if not at high bleeding risk, as recommended by the American Heart Association 3, 5

The American College of Cardiology recommends continuing aspirin 75-162 mg daily indefinitely after stent placement 3
A higher dose of aspirin (162-325 mg daily) is recommended for the initial period after stenting, followed by a maintenance dose of 75-162 mg daily 6
For patients requiring triple therapy, the American College of Cardiology recommends a target INR of 2.0-2.5, low-dose aspirin (75-81 mg), and standard clopidogrel dose (75 mg) 6, 7
Lower-dose aspirin (75-162 mg) is recommended during the initial period after stent implantation in patients with high bleeding risk, as recommended by the American Heart Association and the American College of Cardiology 8, 9

The American College of Cardiology emphasizes the importance of patient education about compliance and the risks of premature discontinuation of antiplatelet therapy 3
Patients must understand the importance of adherence and not to discontinue therapy without medical consultation 3
Patients should be explicitly instructed not to stop antiplatelet therapy without consulting their cardiologist to avoid increasing the risk of stent thrombosis, and should receive clear instructions about medication regimen, activity restrictions, signs/symptoms requiring medical attention, and follow-up appointments before discharge, as recommended by the American Heart Association and the American College of Cardiology 3, 8

Elective non-cardiac surgery should be delayed at least 30 days after BMS placement and at least 6 months after DES placement, and if surgery is needed earlier, aspirin should be maintained if possible, as recommended by the American Heart Association and the American College of Cardiology 10, 11, 3, 8
Drug interactions with PPIs, particularly omeprazole, which may decrease clopidogrel effectiveness, should be considered, and alternative PPIs should be used if GI protection is needed, as recommended by the American Heart Association 5
Genetic variability affecting CYP2C19 function, resulting in poor metabolism of clopidogrel, should be considered, and alternative P2Y12 inhibitors should be used in high-risk patients with known poor metabolizer status, as recommended by the American Heart Association 5

The American College of Cardiology recommends a goal LDL cholesterol <70 mg/dL for very high-risk patients, with high-intensity statin therapy recommended for all patients, as recommended by the European Heart Journal 1, 5
The American Heart Association recommends a goal blood pressure <140/90 mm Hg, with lifestyle modification and pharmacotherapy as needed to achieve this goal, as recommended by the American Heart Association 5
The American Diabetes Association recommends a goal HbA1c <7%, with appropriate glucose-lowering therapy, vigorous modification of other risk factors, and coordination of diabetic care with primary care physician or endocrinologist, as recommended by the American Heart Association and the American College of Cardiology 8, 9
Complete smoking cessation, weight management (BMI goal: 18.5-24.9 kg/m²), and regular physical activity are recommended, as recommended by the American Heart Association 5, 8

The American College of Cardiology recommends that most patients can be safely discharged within 24 hours after uncomplicated coronary stent placement, with same-day discharge being feasible in carefully selected patients, and patients with Acute Coronary Syndrome (ACS) typically require a longer observation period of 24-48 hours, as recommended by the American College of Cardiology 3